Centers for Chemical Innovation (CCI) Phase I Awards and New/Renewal Phase II Centers
Available Formats: HTML: https://www.nsf.gov/pubs/2021/nsf21587/nsf21587.htm?WT.mc_id=USNSF_25&WT.mc_ev=clickPDF: https://www.nsf.gov/pubs/2021/nsf21587/nsf21587.pdf?WT.mc_id=USNSF_25&WT.mc_ev=clickDocument Number: nsf21587Public Comment: This is an NSF Program Announcements and Information item. (Source: NSF Program Announcements and Information)
Source: NSF Program Announcements and Information - May 26, 2021 Category: Science Source Type: funding
BRAIN Initiative: Development and Validation of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in the Brain (R01 Clinical Trial Not Allowed)
Funding Opportunity RFA-MH-21-175 from the NIH Guide for Grants and Contracts. This is a reissue of RFA-MH-19-136. The purpose of this Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative is to encourage applications that will develop and validate novel tools to facilitate the detailed analysis of complex circuits and provide insights into cellular interactions that underlie brain function. The new tools and technologies should inform and/or exploit cell-type and/or circuit-level specificity. Plans for validating the utility of the tool/technology will be an essential feature of a successful ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 27, 2021 Category: Research Source Type: funding
NIH Countermeasures Against Chemical Threats (CounterACT) Early-stage Investigator Research Award (R21 Clinical Trial Not Allowed)
Funding Opportunity PAR-21-209 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to recruit Early Stage Investigators (ESI) to pursue research programs of interest to NIH Chemical Countermeasures Research Program (CCRP) under the Countermeasures Against Chemical Threats (CounterACT) grant/cooperative agreement program. ESI CounterACT R21 projects may be exploratory, applied, proof of principle, or high risk-high impact research to discover safe and effective therapeutics to mitigate toxicities resulting from exposures to highly toxic chemicals. A distinct featur...
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 19, 2021 Category: Research Source Type: funding
Understanding Post-Transcriptional Regulation of Intact and Defective HIV RNA (R61/R33 Clinical Trial Not Allowed)
Funding Opportunity RFA-AI-21-012 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages exploratory and developmental bi-phasic research applications to support the understanding of how HIV RNA chemical modifications impact expression of intact and defective HIV and the identification of potential therapeutic targets for future HIV cure strategies. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 31, 2021 Category: Research Source Type: funding
Notice of Intent to Publish a Funding Opportunity Announcement for NIH Countermeasures Against Chemical Threats (CounterACT) Early-stage Investigator Research Award
Notice NOT-NS-21-030 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 23, 2021 Category: Research Source Type: funding
Screening for Conditions by Electronic Nose Technology (SCENT) (U01 Clinical Trial Optional)
Funding Opportunity RFA-TR-21-009 from the NIH Guide for Grants and Contracts. This FOA is seeking applications for a portable sensing device to detect volatile organic compounds (VOCs, i.e. scents or odors) emanating from skin and to develop a catalog of VOCs as distinct signatures for at least 20 human diseases and conditions. These sensing devices must be able to associate VOC patterns using artificial intelligence to patients with various conditions for diagnostic purposes along with capabilities to incorporate and integrate vital signs. For VOC monitoring, these sensing devices can be Electronic-nose (E-nose) techn...
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 3, 2021 Category: Research Source Type: funding
Notice of NIAID's Participation in PAR-19-039: Countermeasures Against Chemical Threats (CounterACT): Identification of Therapeutic Lead Compounds (U01 Clinical Trial Not Allowed)
Notice NOT-AI-21-026 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 29, 2021 Category: Research Source Type: funding
Notice of NIAID's Participation in PAR-20-316: NIH Countermeasures Against Chemical Threats (CounterACT) Research Centers of Excellence (U54 - Clinical Trial Optional)
Notice NOT-AI-21-029 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 29, 2021 Category: Research Source Type: funding
Notice of NIAID's Participation in PAR-20-253: Countermeasures Against Chemical Threats (CounterACT) Exploratory/Developmental Projects (R21 Clinical Trial Not Allowed)
Notice NOT-AI-21-028 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 29, 2021 Category: Research Source Type: funding
Notice of NIAID's Participation in PAR-19-040: Countermeasures Against Chemical Threats (CounterACT): Optimization of Therapeutic Lead Compounds (U01 Clinical Trial Optional)
Notice NOT-AI-21-027 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 29, 2021 Category: Research Source Type: funding
BRAIN Initiative: New Concepts and Early-Stage Research for Recording and Modulation in the Nervous System (R21) (Clinical Trial Not Allowed)
Funding Opportunity RFA-EY-21-001 from the NIH Guide for Grants and Contracts. A central goal of the BRAIN Initiative is to understand how electrical and chemical signals code information in neural circuits and give rise to sensations, thoughts, emotions and actions. While currently available technologies can provide some understanding, they may not be sufficient to accomplish this goal. For example, non-invasive technologies are low resolution and/or provide indirect measures such as blood flow, which are imprecise; invasive technologies can provide information at the level of single neurons producing the fundamental b...
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 15, 2021 Category: Research Source Type: funding
Dear Colleague Letter: Catalyzing Industry-University Collaboration in Chemical Research through Industry/University Cooperative Research Centers (IUCRCs)
Available Formats: HTML: https://www.nsf.gov/pubs/2021/nsf21036/nsf21036.jsp?WT.mc_id=USNSF_25&WT.mc_ev=clickPDF: https://www.nsf.gov/pubs/2021/nsf21036/nsf21036.pdf?WT.mc_id=USNSF_25&WT.mc_ev=clickDocument Number: nsf21036Public Comment: This is an NSF Program Announcements and Information item. (Source: NSF Program Announcements and Information)
Source: NSF Program Announcements and Information - December 31, 2020 Category: Science Source Type: funding
Countermeasures Against Chemical Threats (CounterACT) Research Centers of Excellence (U54 Clinical Trial Optional)
Funding Opportunity PAR-20-316 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages applications for Countermeasures Against Chemical Threats (CounterACT) Research Centers of Excellence (U54s). The mission of the CounterACT program is to foster and support research and development of new and improved therapeutics for chemical threats. Chemical threats are toxic chemicals that could be used in a terrorist attack or accidentally released from industrial production, storage or shipping. They include traditional chemical warfare agents, toxic industrial chemicals, pharmaceutica...
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 21, 2020 Category: Research Source Type: funding
Molecular Foundations for Biotechnology (MFB)
Letter of Intent Deadline Date: January 14, 2021 Program Guidelines: NSF 21-540This initiative calls for fundamentally new approaches in chemistry to drive new directions in biotechnology, an important Industry of the Future (IotF). Collaborative high risk/high reward projects are sought; the research must involve innovative chemistry.
A multi-year campaign is envisioned (contingent on availability of funding), targeting broad annual themes. This year’s solicitation calls for synergistic scientific partnerships grounded in the principles of ...More at https://www.nsf.gov/funding/pgm_summ.jsp?pims_id=505848&WT.m...
Source: NSF Upcoming Due Dates - December 15, 2020 Category: Science Source Type: funding
Application of Artificial Intelligence and Machine Learning for Advancing Environmental Health Sciences (R41 Clinical Trial Not Allowed)
Funding Opportunity RFA-ES-21-003 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) solicits Phase I (R43) SBIR grant applications from small business concerns (SBCs) to develop promising methodologies using Artificial Intelligence (AI) and Machine Learning (ML) approaches to advance environmental health research and decisions. When developed and validated, these methodologies or approaches will further advance the accuracy of toxicity prediction, help in prioritizing chemicals for more relevant or targeted testing, identify and/or fill data or knowledge gaps in toxicity assessment...
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 10, 2020 Category: Research Source Type: funding
